- Research Article
- 10.1016/j.bpj.2025.11.644
BPS2026 – Profiling pharmacology of GPCRs by time-resolved impedance measurements
- Feb 01, 2026
- Biophysical Journal
- Joachim Wegener + 8 more +8
Publications from 2021 to 2026
Showing 10 of 43 papers
BPS2026 – Profiling pharmacology of GPCRs by time-resolved impedance measurements
Automated patch-clamp for high throughput characterization of subtype-specific induced pluripotent stem cell derived cardiomyocytes
QT risk assessment for the development of oligonucleotide therapeutics - An industry survey sponsored by the Safety Pharmacology Society (SPS) ion channel working group and oligonucleotide safety working group
Contractility-based pharmacological characterization of hiPSC-derived atrial and ventricular cardiomyocytes assessed on the FLEXcyte 96
Development of a high-throughput system for advanced functional cell analysis to predict safety
Membrane potential stimulates ADP import and ATP export by the mitochondrial ADP/ATP carrier due to its positively charged binding site.
The mitochondrial adenosine 5'-diphosphate (ADP)/adenosine 5'-triphosphate (ATP) carrier imports ADP into the mitochondrion and exports ATP to the cell. Here, we demonstrate that 3.3 positive charges are translocated with the negatively charged substrate in each transport step. They can be assigned to three positively charged residues of the central substrate-binding site and two asparagine/arginine pairs. In this way, the membrane potential stimulates not only the ATP4- export step, as a net -0.7 charge is transported, but also the ADP3- import step, as a net +0.3 charge is transported with the electric field. These positive charge movements also inhibit the import of ATP and export of ADP in the presence of a membrane potential, allowing these nucleotides to be maintained at high concentrations in the cytosol and mitochondrial matrix to drive the hydrolysis and synthesis of ATP, respectively. Thus, this is the mechanism by which the membrane potential drives adenine nucleotide exchange with high directional fluxes to fuel the cellular processes.
Read moreDissecting the charge movements during adenine nucleotide exchange by mitochondrial ADP/ATP carrier
Molecular mechanism of choline and ethanolamine transport in humans
Human feline leukaemia virus subgroup C receptor-related proteins 1 and 2 (FLVCR1 and FLVCR2) are members of the major facilitator superfamily1. Their dysfunction is linked to several clinical disorders, including PCARP, HSAN and Fowler syndrome2–7. Earlier studies concluded that FLVCR1 may function as a haem exporter8–12, whereas FLVCR2 was suggested to act as a haem importer13, yet conclusive biochemical and detailed molecular evidence remained elusive for the function of both transporters14–16. Here, we show that FLVCR1 and FLVCR2 facilitate the transport of choline and ethanolamine across the plasma membrane, using a concentration-driven substrate translocation process. Through structural and computational analyses, we have identified distinct conformational states of FLVCRs and unravelled the coordination chemistry underlying their substrate interactions. Fully conserved tryptophan and tyrosine residues form the binding pocket of both transporters and confer selectivity for choline and ethanolamine through cation–π interactions. Our findings clarify the mechanisms of choline and ethanolamine transport by FLVCR1 and FLVCR2, enhance our comprehension of disease-associated mutations that interfere with these vital processes and shed light on the conformational dynamics of these major facilitator superfamily proteins during the transport cycle.
Read moreInvestigation of GABA transport and the GABA/Na+ relationship in human GAT1 using solid supported membrane-based electrophysiology
Cytotoxicity of Colloidal CdSe and CdSe/ZnS Nanoparticles
The synthesis of hydrophobic CdSe, CdSe/ZnS, and Au nanoparticles is described in detail in the supporting information of a previous paper 1 . We have followed these protocols without change. The hydrophobic particles were transferred to aqueous solution using three different protocols. 1) The silanization of CdSe/ZnS particles with phosphonate silane has been described by Gerion et al. 2, 3 and the silanization of CdSe/ZnS particles with PEG silane has been performed as reported by Parak et al. 3 . 2) The polymer coating of Au and CdSe/ZnS particles has been described in detail by Pellegrino et al. 1 . We have followed these protocols without change. The same protocol was applied for the polymer coating of CdSe particles. 3) We have changed our previous protocol in which the transfer of particles to aqueous solution by ligand exchange with mercaptocarbonic acids is described 2 . The protocols for ligand exchange with mercaptocarbonic acids as used in this study are reported below: Coating of CdSe and CdSe/ZnS particles with mercaptopropionic acid First, CdSe or CdSe/ZnS particles (as prepared in organic solvent as described above) were washed one time by precipitating them with methanol and redissolving them in chloroform. The particles were then precipitated by the addition of methanol and the sample was centrifuged and the supernatant discarded. The ligand exchange on the semiconductor particles was carried out by taking the wet precipitate (approximately 10 nmol of red fluorescent particles, or 40 nmol of green fluorescent particles) and adding 2 ml of anhydrous DMF (N,N-Dimethylformamide, purchased from Sigma, #22,705-6). A homogeneous distribution of the particles, which did not dissolve, was established by vortexing the sample. Then, equal molar amounts of mercaptopropionic acid (200 ml, purchased from Sigma, #M580-1) and 2-mercaptoethanol (160 ml, purchased from Sigma, #56,867-2) were added. After vortexing the solution turned transparent in the case of CdSe/ZnS particles. The CdSe cores did not produce a clear solution. This product was stored in the dark at room temperature until actual experiments with the particles were scheduled. Then, the particles were precipitated by adding 2 ml of deionized water and centrifugation. The particles were resuspended in deionized water. The addition of 50-100 ml Base (TMAH dissolved in methanol in a ratio of 1:3, tetramethylammonium hydroxide pentahydrate from Sigma, #T7505) yielded a clear solution with a pH of 10. The solution was then run through two NAP 25 gel columns (purchased from Amersham Biosciences, #17-0852-02) loaded with deionized water in order to neutralize the pH and to clean the product of remaining reactants. Tetraoctylammonium bromide stabilized Au particles dissolved in toluene have been prepared according to standard protocols 4-7 . We have followed the detailed description of the gold synthesis reported by Pellegrino et al. 1 . In this report the tetraoctylammonium bromide ligands were then replaced by dodecanethiol ligands and the particles remained hydrophobic. Here we performed a ligand exchange to mercaptoundecanoic acid, which resulted in hydrophilic and thus water-soluble particles. For the ligand exchange with mercaptoundecanoic acid we followed the protocol of Mayya et al. 8 . 100 ml of tetraoctylammonium bromide stabilized Au particles dissolved in toluene as prepared by Pellegrino et al. 1 were heated to 65°C. A hot solution (65°C) of 5.8 g mercaptoundecanoic acid (MUA, Sigma #45.056-1) dissolved in 10 ml toluene was added. This corresponds to a thirty-fold molar excess of MUA over the initial amount of gold. The solution was kept at 65°C for 1 hour. Then it was stirred overnight at room temperature. The day after a precipitate had formed. The solution was then centrifuged, and the translucent supernatant was discarded. The precipitate was dissolved in 0.1M TRIS buffer and sonicated to obtain a homogeneous, clear, violet solution of mercaptoundecanoic acid stabilized watersoluble Au-particles.
Read more